Eli Lilly’s latest TV ad, unveiled during the Grammys on Sunday night, highlights the importance of early diagnosis for ...

Amid growing concern of the overuse and misuse of obesity drugs, the UK’s pharmacies regulator rolled out stricter guidelines ...

The recent selloff of Eli Lilly, driven by short-term inventory dynamics for its obesity drug, looks overdone ... additional manufacturing capacity online and expect to produce at least 60% ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

A satirical X post saying the three major insulin manufacturers in the United States had announced 2,000%-3,000% price ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

Anti-obesity drug Mounjaro is set to rack up global sales worth nearly £22bn a year by the end of the decade. But Donald ...

The efforts appear to be paying off: The Food and Drug Administration ... with CNBC on Tuesday, Eli Lilly CEO Dave Ricks said the company has "tons of supply coming online" and "that kind of ...

Eli Lilly pre-announced the following drug numbers for Q4 ... We'll also bring additional manufacturing capacity online and expect to produce at least 60% more salable doses of incretins in ...

especially those bought online, outgoing U.S. Food and Drug Administration Commissioner Robert Califf said on Thursday. The sale of these drugs would be less of a problem if the price of the ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...